Scott Paradis Email and Phone Number

Responsible for launching and selling Ruconest, an orphan IV recombinant biologic for the treatment of patients with hereditary angioedema. Accountable for managing a multi-state geography calling on allergist/immunologists in the private practice and institutional setting. Partner with contracted specialty pharmacy providers and a central reimbursement center to coordinate and ensure patient access and support to our product.Responsible for calling on infectious disease specialists and HIV clinics for Xifaxan (hepatic encephalopathy) and Fulyzaq

Successfully launched a buy and bill injectable biologic in the therapeutic toxin marketplace with a miscellaneous J-code.Accountable for sales in teaching institutions, Children's Hospitals, VA Medical Centers, DoD and group practices in a large territory consisting of OH, IN ,WV.-The Cleveland Clinic-Indiana University-Ohio State-Case Western Reserve/University Hospitals-University of Toledo-Marshall University-Rainbow Babies-Akron Children's Hospital-Nationwide Children's Hospital-Riley Children's HospitalAssist accounts with proper billing and reimbursement for Xeomin (incobotulinumtoxinA) with Medicare, Medicaid and commercial insurers.

Successfully launched multiple CNS products with Orphan Drug Status through specialty pharmacy distribution.Responsible for promoting Lundbeck’s CNS franchise to Movement Disorder Specialists and Epileptologists at the Cleveland Clinic and Case Western Reserve/University Hospitals.Worked closely with patient advocacy groups to build awareness for the treatment of rare diseases within our CNS franchise.

Progressed at Janssen from a Primary Care Representative to a Senior CNS Account Manager.